IL6 and systemic inflammatory response syndrome: The objective of our study was to describe the time course of IL-6 as a marker cytokine during treatment with CytoSorb and the effect on clinical conditions, mainly blood pressure and vasopressor requirement, in critically ill patients with different etiology of refractory shock due to SIRS.